Cargando…
Coupling Aptamers to Short Interfering RNAs as Therapeutics
RNA-based approaches are among the most promising strategies aimed at developing safer and more effective therapeutics. RNA therapeutics include small non-coding miRNAs, small interfering RNA, RNA aptamers and more recently, small activating RNAs. However, major barriers exist to the use of RNAs as...
Autores principales: | Cerchia, Laura, Esposito, Carla Lucia, Camorani, Simona, Catuogno, Silvia, de Franciscis, Vittorio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060133/ https://www.ncbi.nlm.nih.gov/pubmed/27721331 http://dx.doi.org/10.3390/ph4111434 |
Ejemplares similares
-
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells
por: Esposito, Carla Lucia, et al.
Publicado: (2014) -
Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
por: Catuogno, Silvia, et al.
Publicado: (2016) -
Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
por: Esposito, Carla Lucia, et al.
Publicado: (2018) -
Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option
por: Catuogno, Silvia, et al.
Publicado: (2018) -
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
por: Esposito, Carla Lucia, et al.
Publicado: (2017)